1. Standish, L, Sweet, E, Kim, E, et al. Recurrence of breast cancer after primary treatment: a matched comparison study of disease-free survival in women who do and do not receive adjunctive naturopathic oncology care. Integr Cancer Ther. 2021;20.
Google Scholar2. Standish, LJ, Sweet, E, Naydis, E, Andersen, MR. Can we demonstrate that breast cancer “integrative oncology“ is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics. Integr Cancer Ther. 2013;12:126-135. doi:10.1177/1534735412447582
Google Scholar | SAGE Journals | ISI3. Andersen, MR, Afdem, K, Hager, S, Gaul, M, Sweet, E, Standish, LJ. The ‘cause’ of my cancer, beliefs about cause among breast cancer patients and survivors who do and do not seek IO care. Psychooncology. 2017;26:248-254. doi:10.1002/pon.4028
Google Scholar | Crossref | Medline4. Standish, LJ, Dowd, F, Sweet, E, et al. Breast cancer integrative oncology care and its costs. Integr Cancer Ther. 2017;16:85-95. doi:10.1177/1534735416649034
Google Scholar | SAGE Journals | ISI5. Standish, LJ, Dowd, F, Sweet, E, Dale, L, Andersen, MR. Do women with breast cancer who choose adjunctive integrative oncology care receive different standard oncologic treatment? Integr Cancer Ther. 2018;17:874-884. doi:10.1177/1534735418769007
Google Scholar | SAGE Journals | ISI6. Andersen, MR, Sweet, E, Hager, S, Gaul, M, Dowd, F, Standish, LJ. Use of integrative oncology, involvement in decision-making, and breast cancer survivor health-related quality of life in the first 5 years postdiagnosis. Integr Cancer Ther. 2018;17:636-645. doi:10.1177/1534735418762543
Google Scholar | SAGE Journals | ISI7. Andersen, MR, Sweet, E, Hager, S, Gaul, M, Dowd, F, Standish, LJ. Effects of Vitamin D use on health-related quality of life of breast cancer patients in early survivorship. Integr Cancer Ther. 2019;18:1534735418822056. doi:10.1177/1534735418822056
Google Scholar | SAGE Journals8. Kim, E, Andersen, MR, Standish, LJ. Receiving/declining adjuvant breast cancer treatments and involvement in treatment decision-making. Complement Ther Med. 2019;43:85-91. doi:10.1016/j.ctim.2019.01.012
Google Scholar | Crossref | Medline9. Ramin, C, Mullooly, M, Schonfeld, SJ, et al. Risk factors for contralateral breast cancer in postmenopausal breast cancer survivors in the NIH-AARP diet and health study. Cancer Causes Control. 2021;32:803-813. doi:10.1007/s10552-021-01432-2
Google Scholar | Crossref | Medline10. Li, CI, Daling, JR, Porter, PL, Tang, MT, Malone, KE. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J Clin Oncol. 2009;27:5312-5318. doi:10.1200/JCO.2009.23.1597
Google Scholar | Crossref | Medline11. Knight, JA, Fan, J, Malone, KE, et al. Alcohol consumption and cigarette smoking in combination: a predictor of contralateral breast cancer risk in the WECARE study. Int J Cancer. 2017;141:916-924. doi:10.1002/ijc.30791
Google Scholar | Crossref | Medline12. Simapivapan, P, Boltong, A, Hodge, A. To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer? A systematic review. Cancer Treat Rev. 2016;50:155-167. doi:10.1016/j.ctrv.2016.09.010
Google Scholar | Crossref | Medline13. Akdeniz, D, Klaver, MM, Smith, CZA, Koppert, LB, Hooning, MJ. The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis. Cancer Causes Control. 2020;31:403-416. doi:10.1007/s10552-020-01284-2
Google Scholar | Crossref | Medline14. DiMarzio, P, Peila, R, Dowling, O, et al. Smoking and alcohol drinking effect on radiotherapy associated risk of second primary cancer and mortality among breast cancer patients. Cancer Epidemiol. 2018;57:97-103. doi:10.1016/j.canep.2018.10.002
Google Scholar | Crossref | Medline15. Sánchez, L, Lana, A, Hidalgo, A, et al. Risk factors for second primary tumours in breast cancer survivors. Eur J Cancer Prev. 2008;17:406-413. doi:10.1097/CEJ.0b013e3282f75ee5
Google Scholar | Crossref | Medline16. Kristoffersen, AE, Fønnebø, V, Norheim, AJ. Do cancer patients with a poor prognosis use complementary and alternative medicine more often than others? J Altern Complement Med. 2009;15:35-40. doi:10.1089/acm.2008.0262
Google Scholar | Crossref | Medline | ISI17. Matthews, AK, Sellergren, SA, Huo, D, List, M, Fleming, G. Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med. 2007;13:555-562. doi:10.1089/acm.2007.03-9040
Google Scholar | Crossref | Medline | ISI18. Stein, KD, Kaw, C, Crammer, C, Gansler, T. The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2009;115:4397-4408. doi:10.1002/cncr.24591
Google Scholar | Crossref | Medline | ISI19. Söllner, W, Maislinger, S, DeVries, A, Steixner, E, Rumpold, G, Lukas, P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2000;89:873-880. doi:10.1002/1097-0142(20000815)89:4<873::aid-cncr21>3.0.co;2-k
Google Scholar | Crossref | Medline | ISI20. Wang, X, Wang, N, Zhong, L, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020;25:3186-3197. doi:10.1038/s41380-020-00865-6
Google Scholar | Crossref | Medline21. Zörgő, S, Peters, GY, Mkhitaryan, S. Attitudes underlying reliance on complementary and alternative medicine. Integr Cancer Ther. 2020;19:1-14. doi:10.1177/1534735420910472
Google Scholar | SAGE Journals22. Block, KI, Gyllenhaal, C, Tripathy, D, et al. Survival impact of integrative cancer care in advanced metastatic breast cancer. Breast J. 2009;15:357-366. doi:10.1111/j.1524-4741.2009.00739.x
Google Scholar | Crossref | Medline23. Segev, Y, Lavie, O, Stein, N, et al. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer. Support Care Cancer. 2021;29:4055-4064. doi:10.1007/s00520-020-05961-5
Google Scholar | Crossref | Medline24. Neuhouser, ML, Smith, AW, George, SM, et al. Use of complementary and alternative medicine and breast cancer survival in the health, eating, activity, and lifestyle study. Breast Cancer Res Treat. 2016;160:539-546. doi:10.1007/s10549-016-4010-x
Google Scholar | Crossref | Medline25. Arun, B, Austin, T, Babiera, GV, et al. A comprehensive lifestyle randomized clinical trial: design and initial patient experience. Integr Cancer Ther. 2017;16:3-20. doi:10.1177/1534735416679516
Google Scholar | SAGE Journals | ISI26. Zhai, XF, Liu, XL, Shen, F, Fan, J, Ling, CQ. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: a randomized controlled study. Cancer. 2018;124:2161-2168. doi:10.1002/cncr.30915
Google Scholar | Crossref | Medline